🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07426432
Active, not recruiting Not applicable

Evaluate the Effect of Fluoride-Releasing Composite Resin on Prevention of White Spot Lesions During Clear Aligner Therapy

NCT07426432 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-01
Last updated
2026-02-23

Condition(s) studied

White Spot LesionsClear Aligner Appliance

Investigational drug(s) / intervention(s)

Application of fluoride-releasing compositeApplication of conventional composite

Application of fluoride-releasing composite: using fluoride releasing composite for attachment construction

Application of conventional composite: using non fluoridated composite for attachment construction

Study summary

Aim of this study: evaluate the effect of fluoride-releasing composite resin as attachments on prevention of white spot lesions.

Material and methods:

Type: Prospective, randomized split mouth controlled study.

Interventions:

Intervention Group (Experimental Side):

•Application of fluoride-releasing composite

Control Group (Control Side):

•Application of conventional composite

Outcome Measures:

Primary Outcome: Incidence and Severity of White Spot Lesions

Secondary Outcomes:

1. Periodontal Ligament (PDL) Health
2. Gingival Bleeding and Inflammation

Eligibility

Sex
ALL
Min age
16 Years
Max age
24 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients aged 16-24 years. * Good general and oral health. * Mild dental crowding per arch (≤ 4 mm). Exclusion Criteria: * Systemic conditions affecting tooth movement (e.g., diabetes, bone disorders). * Patients with Cleft lip and palate. * Previous orthodontic treatment. * Dental fluorosis. * Hypocalcified teeth or visible demineralization.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Mansoura University Al Mansurah Egypt

More Mansoura University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07426432 on ClinicalTrials.gov ↗ ← All trials in Egypt